Item 8.01. Other Events.

On April 23, 2020, Surface Oncology, Inc. issued a press release announcing the first patient dosed in a clinical trial of immuno-oncology candidate SRF388. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit
Number                                    Description
99.1        Press release issued by Surface Oncology, Inc. dated April 23, 2020




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses